A mutant prion protein displays an aberrant membrane association when expressed in cultured cells

S Lehmann1, D A Harris

  • 1Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Insights

Mutant prion protein (PrP) in inherited prion diseases shows altered membrane attachment. Even after GPI anchor cleavage, the mutant PrP remains cell-surface bound, suggesting novel interactions in prion disease pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Inherited prion diseases are linked to mutations in the prion protein (PrP) gene.
  • PrP is a cell surface protein attached via a glycosyl-phosphatidylinositol (GPI) anchor.
  • A specific mutation involves extra octapeptide repeats, associated with familial Creutzfeldt-Jakob disease.

Purpose of the Study:

  • To analyze the membrane attachment of a mutant murine PrP homologue in cultured cells.
  • To investigate if the mutant PrP exhibits altered membrane association compared to wild-type PrP.

Main Methods:

  • Cultured Chinese hamster ovary (CHO) cells expressing wild-type and mutant murine PrP.
  • Analysis of PrP glycosylation, GPI anchoring, and cell surface expression.
  • Treatment with phosphatidylinositol-specific phospholipase C (PI-PLC) to cleave the GPI anchor.
  • Hydrophobicity and membrane association assays using Triton X-114 and carbonate buffer.

Main Results:

  • The mutant PrP is glycosylated, GPI-anchored, and expressed on the cell surface, similar to wild-type PrP.
  • Cleavage of the GPI anchor by PI-PLC did not release the mutant PrP from intact cells.
  • The phospholipase-treated mutant PrP demonstrated hydrophobic properties and tight membrane association.

Conclusions:

  • Mutant PrP exhibits an additional, non-GPI-mediated mode of membrane attachment.
  • This altered membrane association may involve polypeptide integration, self-association, or binding to other membrane proteins.
  • Changes in PrP membrane association are potentially significant in the development of prion diseases.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...